Navigation Links
GenTel licenses next generation cancer research

Madison, Wis. - Recent biochemical research into certain forms of cancer has focused on disease-related changes in the protein composition of blood. As these studies progress, significant lines of inquiry will examine not only the protein changes induced by cancer but changes in the sugar molecules that naturally attach to those proteins.

In the serum of pancreatic cancer patients,......

Full article >>> roteins (such as antibodies) in a process called glycosylation. This process occurs as part of biosynthesis and is an important determinant of protein function.

Changes in glycosylation are thought to play roles in certain disease processes.

GenTel's technology modifies the normal sugar molecules associated with antibodies printed on GenTel's arrays so that they are no longer rea......

Full article >>> ollow.

Added Nelson: "We're going to make this available to a much broader audience. We're going to expand it to look at prostate and other cancers."

The market for tumor serum analyte in-vitro diagnostic tests is approximately $1 billion per year worldwide, Negm said. Although nobody has an exact number on the glycosylation segment of that market, Negm believes that GenTel's fir......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 08/17/06


Related biology technology :

1. GenTel acquires GlaxoSmithKline chip platform
2. New angel capital centered on GenTel agreement with big pharma
3. GenTel to distribute cancer research tool
4. GenTel gets federal grant to develop allergy test
5. Madisons GenTel partners with Taiwan firm
6. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
7. GenTel BioSurfaces launches new assay platform
8. GenTel will sell Dutch firms biomolecule labeling technology
9. Bone Care, GenTel, MyWeather
10. GenTel receives $250,000 state loan
11. GenTel claims $900,000 in federal grants this year for biochip research
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... and solutions to the healthcare market. The company's primary focus is on new ... and marketing strategies that are necessary to help companies efficiently bring their products ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
Breaking Biology Technology:
(Date:6/2/2016)... -- The Department of Transport Management (DOTM) of ... US Dollar project, for the , Supply and ... and IT Infrastructure , to Decatur ... of Identity Management Solutions. Numerous renowned international vendors participated in ... was selected for the most compliant and innovative solution. ...
(Date:6/2/2016)... 2016 Perimeter Surveillance & Detection ... Physical Infrastructure, Support & Other Service  The ... offers comprehensive analysis of the global Border Security ... revenues of $17.98 billion in 2016. Now: ... leader in software and hardware technologies for advanced video ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):